RPG Life Sciences

RPG Life Sciences Limited is an integrated pharmaceutical company with a global reach, primarily operating in India. Their business model encompasses the entire pharmaceutical value chain, from the development and manufacture of active pharmaceutical ingredients (APIs) to the marketing and distribution of finished dosage formulations (FDFs). This vertical integration provides them with significant control over their supply chain and product quality.

A core component of their business is the production of synthetic APIs across a wide range of therapeutic areas. These include immunosuppressants, anti-psychotics, anti-anginals, anthelmintics, anti-convulsants, and anti-spasmodics, among others. This focus on API manufacturing provides a foundation for their broader pharmaceutical operations and allows them to supply both their own finished formulations and external customers.

Beyond APIs, RPG Life Sciences also manufactures and markets a vast portfolio of generic and branded finished dosage formulations (FDFs). Their product range covers an extensive spectrum of therapeutic areas, including nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional supplements, diabetology, respiratory medications, neuropsychiatry, urology, vitamins and minerals, gastrointestinal treatments, pain management, anti-diabetic medications, gynecological products, cardiovascular drugs, pediatric medications, neurological treatments, anti-dengue medications, and dermatological products. This broad portfolio caters to a diverse range of patient needs and market segments.

The company’s history dates back to 1968, showcasing a long-standing presence in the pharmaceutical industry. Currently headquartered in Mumbai, India, RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. The company's name changed from RPG Pharmaceuticals Limited to its current name in February 2008, reflecting its broader scope of operations beyond just pharmaceuticals.